Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?

Author： Barbot M.   Albiger N.   Ceccato F.   Zilio M.   Frigo A.   Denaro L.   Mantero F.   Scaroni C.  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.17, Iss.2, 2014-04, pp. : 109-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cushing’s disease

By De Martin Martina   Giraldi Francesca   Cavagnini Francesco  

Pituitary, Vol. 9, Iss. 4, 2006-12 ,pp. : 279-287

Springer Publishing Company

Access to resources Recommend Favorite

Disease-specific quality of life evaluation and its determinants in Cushing’s syndrome: what have we learnt?

By Badia X.   Valassi E.   Roset M.   Webb S.  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 187-195

Springer Publishing Company

Access to resources Recommend Favorite

Is “Cushing’s disease of the omentum” an affliction of mouse and men?

By Walker B.  

Diabetologia, Vol. 47, Iss. 5, 2004-05 ,pp. : 767-769

Springer Publishing Company

Access to resources Recommend Favorite

Imaging of the Pituitary Gland in Cushing’s Disease

By  

Medical Principles and Practice, Vol. 7, Iss. 4, 1998-11 ,pp. : 246-250

Karger

Access to resources Recommend Favorite

Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing’s disease

By Pas R.   Bruin C.   Pereira A.   Romijn J.   Netea-Maier R.   Hermus A.   Zelissen P.   Jong F.   Lely A.   Herder W.   Webb S.   Lamberts S.   Hofland L.   Feelders R.  

Pituitary, Vol. 16, Iss. 4, 2013-12 ,pp. : 536-544

Springer Publishing Company

Access to resources Recommend Favorite